Identification of novel inhibitors of UDP-Glc4/-epimerase, a validated drug target for african sleeping sickness

M. D. Urbaniak, Jioji Natadra Tabudravu, A. Msaki, K. Mansfield Matera, R. Brenk, Marcel Jaspars, M. A. J. Ferguson

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Novel inhibitors of Trypanosoma brucei and mammalian UDP-Glc 4'-epimerase were identified by screening a small library of natural products and commercially available drug-like molecules. The inhibitors possess low micromolar potency against the T brucei and human enzymes in vitro, display a degree of selectivity between the two enzymes, and are cytotoxic to cultured T. brucei and mammalian cells. (c) 2006 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)5744-5747
Number of pages3
JournalBioorganic & Medicinal Chemistry
Volume16
DOIs
Publication statusPublished - 2006

Keywords

  • epimerase
  • UDP-Glc 4 '-epimerase
  • UDP-glucose
  • UDP-galactose
  • Trypanosoma brucei
  • trypanosome
  • POLY-N-ACETYLLACTOSAMINE
  • TRYPANOSOMA-BRUCEI
  • GALACTOSE METABOLISM
  • GLYCOSYLATION
  • GLYCOPROTEINS

Cite this

Identification of novel inhibitors of UDP-Glc4/-epimerase, a validated drug target for african sleeping sickness. / Urbaniak, M. D.; Tabudravu, Jioji Natadra; Msaki, A.; Mansfield Matera, K.; Brenk, R.; Jaspars, Marcel; Ferguson, M. A. J.

In: Bioorganic & Medicinal Chemistry, Vol. 16, 2006, p. 5744-5747.

Research output: Contribution to journalArticle

@article{452a2b65affe4b4788b7c8c91c85de3d,
title = "Identification of novel inhibitors of UDP-Glc4/-epimerase, a validated drug target for african sleeping sickness",
abstract = "Novel inhibitors of Trypanosoma brucei and mammalian UDP-Glc 4'-epimerase were identified by screening a small library of natural products and commercially available drug-like molecules. The inhibitors possess low micromolar potency against the T brucei and human enzymes in vitro, display a degree of selectivity between the two enzymes, and are cytotoxic to cultured T. brucei and mammalian cells. (c) 2006 Elsevier Ltd. All rights reserved.",
keywords = "epimerase, UDP-Glc 4 '-epimerase, UDP-glucose, UDP-galactose, Trypanosoma brucei, trypanosome, POLY-N-ACETYLLACTOSAMINE, TRYPANOSOMA-BRUCEI, GALACTOSE METABOLISM, GLYCOSYLATION, GLYCOPROTEINS",
author = "Urbaniak, {M. D.} and Tabudravu, {Jioji Natadra} and A. Msaki and {Mansfield Matera}, K. and R. Brenk and Marcel Jaspars and Ferguson, {M. A. J.}",
year = "2006",
doi = "10.1016/j.bmcl.2006.08.091",
language = "English",
volume = "16",
pages = "5744--5747",
journal = "Bioorganic & Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Identification of novel inhibitors of UDP-Glc4/-epimerase, a validated drug target for african sleeping sickness

AU - Urbaniak, M. D.

AU - Tabudravu, Jioji Natadra

AU - Msaki, A.

AU - Mansfield Matera, K.

AU - Brenk, R.

AU - Jaspars, Marcel

AU - Ferguson, M. A. J.

PY - 2006

Y1 - 2006

N2 - Novel inhibitors of Trypanosoma brucei and mammalian UDP-Glc 4'-epimerase were identified by screening a small library of natural products and commercially available drug-like molecules. The inhibitors possess low micromolar potency against the T brucei and human enzymes in vitro, display a degree of selectivity between the two enzymes, and are cytotoxic to cultured T. brucei and mammalian cells. (c) 2006 Elsevier Ltd. All rights reserved.

AB - Novel inhibitors of Trypanosoma brucei and mammalian UDP-Glc 4'-epimerase were identified by screening a small library of natural products and commercially available drug-like molecules. The inhibitors possess low micromolar potency against the T brucei and human enzymes in vitro, display a degree of selectivity between the two enzymes, and are cytotoxic to cultured T. brucei and mammalian cells. (c) 2006 Elsevier Ltd. All rights reserved.

KW - epimerase

KW - UDP-Glc 4 '-epimerase

KW - UDP-glucose

KW - UDP-galactose

KW - Trypanosoma brucei

KW - trypanosome

KW - POLY-N-ACETYLLACTOSAMINE

KW - TRYPANOSOMA-BRUCEI

KW - GALACTOSE METABOLISM

KW - GLYCOSYLATION

KW - GLYCOPROTEINS

U2 - 10.1016/j.bmcl.2006.08.091

DO - 10.1016/j.bmcl.2006.08.091

M3 - Article

VL - 16

SP - 5744

EP - 5747

JO - Bioorganic & Medicinal Chemistry

JF - Bioorganic & Medicinal Chemistry

SN - 0968-0896

ER -